Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Singapore Platform for Controlled Human Infections With SARS-CoV-2

NCT06654973 is registered in ClinicalTrials.gov with Tan Tock Seng Hospital as lead sponsor.

NCT NCT06654973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06654973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Singapore Platform for Controlled Human Infections With SARS-CoV-2
Lead sponsor
Tan Tock Seng Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 27, 2024
Completion date
December 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19